At a glance: Health systems are using AI to modernize utilization review within the mid-revenue cycle, reducing avoidable denials, speeding reviews, and easing staffing pressure by helping teams focus on the cases that need the most attention.
The mid-revenue cycle is where a lot of hospital revenue quietly slips away. Denials climb. Manual reviews pile up. And every disputed status determination adds friction to an already strained relationship with payers. For financial and revenue cycle leaders, the pressure is real, and the old playbook of appealing denials after the fact isn’t cutting it.
A better approach is taking hold. Leading health systems are taking a new approach by layering predictive AI on top of standardized workflows to identify and prioritize cases by risk before they become a denial. That shift is gaining broader attention, too: HealthLeaders recently named the combined work of Baylor Scott & White, Inova Health, and Summit Healthcare among the five top revenue cycle stories defining the year.
Here’s how the shift took place, and the outcomes that followed.
For years, utilization review lived off to the side. Nurses checked patient status against static criteria, and finance dealt with the fallout when a payer disagreed. That gap between the clinical decision and the financial outcome is exactly where revenue leaks.
Bringing utilization review under the revenue cycle umbrella closes that gap. When medical necessity is validated in real time, the reasoning behind each status determination travels with the case from admission to final payment. Finance is not reconstructing a decision weeks later to fight an appeal. The right call gets made and documented upfront, and appropriate revenue is captured from day one.
This matters because many denials trace back to a status decision that was clinically sound but not sufficiently supported when the payer asked. Tightening that connection turns utilization review from a compliance chore into a revenue protection strategy.
AI is only as good as the process it runs on. Layer predictive technology onto inconsistent workflows, and you get faster inconsistency, not better outcomes.
The health systems seeing the strongest results did the unglamorous work first. They standardized how reviews get done, clarified who owns each step, and built consistency across facilities before switching on AI. That foundation is what lets predictive scoring do its job: surfacing the cases that need the most attention and reducing the manual administrative work required for consistent, accurate reviews.
For revenue cycle leaders evaluating AI, the takeaway is direct. Solidify your workflows first. A clean process gives AI something reliable to build on, and it is the difference between technology that scales and technology that amplifies existing problems.
Volume keeps climbing. Staffing budgets do not. That squeeze is one of the biggest reasons health systems are turning to AI in the mid-revenue cycle.
Predictive technology changes the math. Instead of asking nurses to review every chart the same way, AI helps teams prioritize cases based on risk and clinical acuity. It surfaces high-risk clinical outliers that require the most human attention, reducing the manual administrative burden associated with routine cases. The result is more capacity from the same team, and more of their time spent on work that truly requires clinical expertise.
That is how these organizations absorbed growing volume without expanding headcount, and why staff satisfaction often rises alongside efficiency.
The outcomes across three Xsolis clients show what this shift produces:
These are not marginal gains. A 60% drop in initial denials reshapes the downstream appeals workload. A 61% reduction in review time frees clinicians for higher-value work. Together, they point to the same conclusion: real-time accuracy at the front-end beats reactive appeals at the back-end.
The bigger story here is a change in mindset. For a long time, revenue cycle teams treated denials as a cost of doing business, something to fight after the fact. AI-driven utilization review flips that logic. It moves the work upstream, to the moment of decision, where getting status right prevents an unnecessary denial from happening in the first place.
Concurrent review, powered by predictive scoring, gives providers a more objective view of the patient while helping teams prepare for payer conversations with stronger clinical support. Fewer disputes. Faster determinations. Less administrative waste on both sides. That is a healthier revenue cycle and a healthier payer relationship at the same time.
If your team is still spending most of its energy on appeals, it may be time to look more closely at where those denials start. Real-time visibility changes the equation by helping teams address medical necessity issues during the stay, before they turn into downstream denials and appeals.
For a closer look at how these ideas played out in practice, read HealthLeaders’ earlier coverage of Baylor Scott & White, Inova, and Summit Healthcare in How AI Enables Mid-Revenue Cycle Optimization. You can also explore independent research on the accuracy of Xsolis’ AI models, including a study conducted with Baylor Scott & White.
Mid-revenue cycle utilization review is the process of validating patient status and medical necessity during the hospital stay, rather than after discharge. Bringing it into the revenue cycle connects clinical decisions directly to financial outcomes, which helps prevent denials and protect revenue.
Yes. Standardizing and clarifying workflows before deploying AI produces far better results. AI amplifies whatever process it runs on, so a clean, consistent workflow lets predictive technology prioritize cases accurately instead of scaling existing inefficiencies.
Financial and revenue cycle leaders at hospitals and health systems benefit most, especially those facing rising denial rates, staff shortages, or payer friction. The approach protects revenue, improves labor efficiency, and strengthens payer collaboration.
AI evaluates real-time clinical data to predict the appropriate level of care for each patient. This gives utilization review teams objective, well-documented support for status determinations, so payers are less likely to deny the claim. Summit Healthcare saw a 60% reduction in initial medical necessity denials using this approach.
Yes. AI helps teams focus on the cases that need the most attention while reducing manual administrative work on clearer-cut reviews. This lets teams handle rising volume without adding staff. Baylor Scott & White reduced its staffing burden by 25% while cutting initial review time by 61%.